Patents by Inventor Warren Huff

Warren Huff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911395
    Abstract: The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: February 27, 2024
    Assignee: REATA PHARMACEUTICALS HOLDINGS, LLC
    Inventors: Colin J. Meyer, Warren Huff
  • Publication number: 20230255982
    Abstract: The present invention provides methods of treating patients infected with a coronavirus. In particular, provided are methods of treating or preventing COVID-19, or symptoms or complications thereof, in patients in need thereof using bardoxolone methyl or analogs thereof, and/or preventing the onset of COVID-19 in patients infected with SARS-COV-2.
    Type: Application
    Filed: May 7, 2021
    Publication date: August 17, 2023
    Applicant: REATA PHARMACEUTICALS HOLDINGS, LLC
    Inventors: Deborah FERGUSON, W. Christian WIGLEY, Colin MEYER, J. Warren HUFF, Robert M. KRAL, Jr.
  • Publication number: 20190076443
    Abstract: The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.
    Type: Application
    Filed: September 13, 2018
    Publication date: March 14, 2019
    Inventors: Colin J. MEYER, Warren HUFF
  • Patent number: 10105372
    Abstract: The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.
    Type: Grant
    Filed: April 12, 2011
    Date of Patent: October 23, 2018
    Assignee: REATA PHARMACEUTICALS, INC.
    Inventors: Colin J. Meyer, Warren Huff
  • Publication number: 20110281955
    Abstract: The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.
    Type: Application
    Filed: April 12, 2011
    Publication date: November 17, 2011
    Applicant: REATA PHARMACEUTICALS
    Inventors: Colin J. Meyer, Warren Huff